Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2014 12:33 ET | Source: Novavax, Inc.

Novavax Appoints Dr. Cindy Oliver as Senior Vice President, Process Development Operations

GAITHERSBURG, Md., April 7, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
April 02, 2014 16:10 ET | Source: Novavax, Inc.

Novavax to Present at the 13th Annual Needham Healthcare Conference

GAITHERSBURG, Md., April 2, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer, will...
March 10, 2014 16:14 ET | Source: Novavax, Inc.

Novavax Reports Fourth-Quarter and Year-End 2013 Financial Results and Initiation of Phase 1/2 Clinical Trial of Its H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M(TM)

GAITHERSBURG, Md., March 10, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
March 10, 2014 08:30 ET | Source: Novavax, Inc.

Novavax Appoints John J. Trizzino as Senior Vice President, Commercial Operations

GAITHERSBURG, Md., March 10, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
February 27, 2014 16:15 ET | Source: Novavax, Inc.

Novavax Announces Extension of Contract for Advanced Development of Recombinant Influenza Products and Pandemic Preparedness With HHS-BARDA

GAITHERSBURG, Md., Feb. 27, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the execution of a contract modification to extend the base period of performance of its current...
February 19, 2014 16:28 ET | Source: Novavax, Inc.

Novavax to Report Fourth Quarter and Year-End 2013 Financial Results on March 10, 2014

ROCKVILLE, Md., Feb. 19, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it will host a conference call and webcast to report its fourth quarter and year-end 2013 financial...
January 13, 2014 08:00 ET | Source: Novavax, Inc.

Novavax Announces Management Promotions to Support Expanded Clinical Activity in 2014

ROCKVILLE, Md., Jan. 13, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced a number of promotions within its clinical operations group in preparation for expanded clinical trial...
January 13, 2014 08:00 ET | Source: Novavax, Inc.

Novavax Announces Continuation of RSV Vaccine Partnership With PATH

ROCKVILLE, Md., Jan. 13, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced the continuation of their partnership with PATH to develop Novavax' RSV (respiratory syncytial virus) vaccine...
November 26, 2013 16:05 ET | Source: Novavax, Inc.

Novavax to Present at the 25th Annual Piper Jaffray Healthcare Conference

ROCKVILLE, Md., Nov. 26, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer, will...
November 13, 2013 17:01 ET | Source: Novavax, Inc.

New England Journal of Medicine Publishes Positive Data From Clinical Trial of Novavax' Vaccine Against H7N9 Avian Flu

Data are industry's first from clinical trial of vaccine against A(H7N9) strain of influenza 81% of 5ug adjuvanted vaccine recipients had protective HAI levels 97% of 5ug adjuvanted...